(+)-dexrazoxane multiple interactions ISO RGD:731978 6480464 [Dexrazoxane co-treated with Doxorubicin] results in decreased expression of CCDC80 protein CTD PMID:30517846 1,2-dichloroethane decreases expression ISO RGD:731978 6480464 ethylene dichloride results in decreased expression of CCDC80 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of CCDC80 mRNA CTD PMID:27840820 1,2-dimethylhydrazine multiple interactions ISO RGD:731978 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCDC80 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:731978 6480464 Ethinyl Estradiol affects the expression of CCDC80 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CCDC80 mRNA CTD PMID:17557909 17beta-estradiol affects expression ISO RGD:736330 6480464 Estradiol affects the expression of CCDC80 mRNA CTD PMID:22574217 17beta-estradiol multiple interactions ISO RGD:736330 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of CCDC80 mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:731978 6480464 Estradiol results in increased expression of CCDC80 mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731978 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCDC80 mRNA CTD PMID:23994337 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731978 6480464 Tetrachlorodibenzodioxin affects the expression of CCDC80 mRNA CTD PMID:21570461 , PMID:26377647 2-hydroxypropanoic acid decreases expression ISO RGD:736330 6480464 Lactic Acid results in decreased expression of CCDC80 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:731978 6480464 3 more ... CTD PMID:23994337 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CCDC80 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases expression ISO RGD:731978 6480464 bis4-hydroxyphenylsulfone results in increased expression of CCDC80 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:731978 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of CCDC80 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:731978 6480464 Fenretinide results in decreased expression of CCDC80 mRNA CTD PMID:28973697 8-Br-cAMP decreases expression ISO RGD:736330 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCDC80 mRNA CTD PMID:22079614 all-trans-retinoic acid increases expression ISO RGD:736330 6480464 Tretinoin results in increased expression of CCDC80 mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:731978 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of CCDC80 mRNA more ... CTD PMID:30951980 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of CCDC80 mRNA CTD PMID:30779732 aristolochic acid multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of CCDC80 mRNA CTD PMID:23912714 benzo[a]pyrene decreases expression ISO RGD:731978 6480464 Benzoapyrene results in decreased expression of CCDC80 mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:736330 6480464 Benzoapyrene results in increased expression of CCDC80 mRNA CTD PMID:32234424 benzo[a]pyrene increases expression ISO RGD:731978 6480464 Benzoapyrene results in increased expression of CCDC80 mRNA CTD PMID:32417428 benzo[a]pyrene increases methylation ISO RGD:736330 6480464 Benzoapyrene results in increased methylation of CCDC80 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:736330 6480464 Benzoapyrene results in decreased expression of CCDC80 mRNA CTD PMID:22178795 beta-naphthoflavone decreases expression ISO RGD:731978 6480464 beta-Naphthoflavone results in decreased expression of CCDC80 mRNA CTD PMID:23994337 bilirubin IXalpha decreases expression ISO RGD:736330 6480464 Bilirubin results in decreased expression of CCDC80 mRNA CTD PMID:20196124 bisphenol A decreases methylation ISO RGD:736330 6480464 bisphenol A results in decreased methylation of CCDC80 gene CTD PMID:22576693 bisphenol A multiple interactions ISO RGD:731978 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of CCDC80 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:731978 6480464 bisphenol A results in increased expression of CCDC80 mRNA CTD PMID:30951980 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CCDC80 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:736330 6480464 bisphenol A results in increased expression of CCDC80 mRNA CTD PMID:22576693 bisphenol F multiple interactions ISO RGD:731978 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of CCDC80 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:731978 6480464 bisphenol F results in increased expression of CCDC80 mRNA CTD PMID:30951980 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of CCDC80 mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:736330 6480464 butyraldehyde results in decreased expression of CCDC80 mRNA CTD PMID:26079696 calcitriol decreases expression ISO RGD:736330 6480464 Calcitriol results in decreased expression of CCDC80 mRNA CTD PMID:26485663 carbon nanotube affects expression ISO RGD:731978 6480464 Nanotubes, Carbon analog affects the expression of CCDC80 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:731978 6480464 Nanotubes, Carbon analog results in decreased expression of CCDC80 mRNA CTD PMID:25620056 carbon nanotube increases expression ISO RGD:731978 6480464 Nanotubes, Carbon results in increased expression of CCDC80 mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:731978 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCDC80 mRNA CTD PMID:20938992 cisplatin multiple interactions ISO RGD:736330 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CCDC80 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:736330 6480464 Cisplatin results in decreased expression of CCDC80 mRNA CTD PMID:27392435 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCDC80 mRNA CTD PMID:17602206 copper atom multiple interactions ISO RGD:736330 6480464 [NSC 689534 binds to Copper] which results in increased expression of CCDC80 mRNA CTD PMID:20971185 copper atom multiple interactions ISO RGD:731978 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CCDC80 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:736330 6480464 [NSC 689534 binds to Copper] which results in increased expression of CCDC80 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:731978 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CCDC80 mRNA CTD PMID:15467011 CU-O LINKAGE decreases expression ISO RGD:736330 6480464 cupric oxide results in decreased expression of CCDC80 mRNA CTD PMID:22077320 dioxygen increases expression ISO RGD:736330 6480464 Oxygen deficiency results in increased expression of CCDC80 mRNA CTD PMID:20042640 diuron decreases expression EXP 6480464 Diuron results in decreased expression of CCDC80 mRNA CTD PMID:21551480 , PMID:25152437 dorsomorphin multiple interactions ISO RGD:736330 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:731978 6480464 Doxorubicin results in decreased expression of CCDC80 protein CTD PMID:30517846 doxorubicin affects expression ISO RGD:736330 6480464 Doxorubicin affects the expression of CCDC80 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:731978 6480464 [Dexrazoxane co-treated with Doxorubicin] results in decreased expression of CCDC80 protein CTD PMID:30517846 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CCDC80 mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:736330 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CCDC80 mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:736330 6480464 entinostat results in decreased expression of CCDC80 mRNA CTD PMID:26272509 ethanol increases expression ISO RGD:731978 6480464 Ethanol results in increased expression of CCDC80 mRNA CTD PMID:30319688 fipronil increases expression EXP 6480464 fipronil results in increased expression of CCDC80 mRNA CTD PMID:23962444 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CCDC80 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:731978 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 formaldehyde increases expression ISO RGD:736330 6480464 Formaldehyde results in increased expression of CCDC80 mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of CCDC80 mRNA CTD PMID:27387713 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:731978 6480464 indeno1 more ... CTD PMID:26377693 isoprenaline increases expression ISO RGD:731978 6480464 Isoproterenol results in increased expression of CCDC80 mRNA CTD PMID:20003209 L-methionine multiple interactions ISO RGD:731978 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CCDC80 mRNA CTD PMID:20938992 lead diacetate decreases expression ISO RGD:731978 6480464 lead acetate results in decreased expression of CCDC80 mRNA CTD PMID:20542052 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of CCDC80 mRNA CTD PMID:24136188 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of CCDC80 mRNA CTD PMID:25972201 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CCDC80 mRNA CTD PMID:17602206 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of CCDC80 mRNA CTD PMID:24136188 nickel sulfate decreases expression ISO RGD:736330 6480464 nickel sulfate results in decreased expression of CCDC80 mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of CCDC80 mRNA CTD PMID:24136188 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CCDC80 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CCDC80 mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:731978 6480464 Acetaminophen affects the expression of CCDC80 mRNA CTD PMID:17562736 rac-lactic acid decreases expression ISO RGD:736330 6480464 Lactic Acid results in decreased expression of CCDC80 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:736330 6480464 Resveratrol results in decreased expression of CCDC80 mRNA CTD PMID:25888808 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CCDC80 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:736330 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:736330 6480464 Silicon Dioxide analog results in decreased expression of CCDC80 mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO RGD:736330 6480464 sodium arsenite results in decreased expression of CCDC80 mRNA CTD PMID:22714537 sulforaphane increases expression ISO RGD:731978 6480464 sulforafan results in increased expression of CCDC80 mRNA CTD PMID:30529165 sulforaphane decreases expression ISO RGD:736330 6480464 sulforafan results in decreased expression of CCDC80 mRNA CTD PMID:31838189 tamoxifen affects expression ISO RGD:731978 6480464 Tamoxifen affects the expression of CCDC80 mRNA CTD PMID:17555576 tetrachloromethane affects expression ISO RGD:731978 6480464 Carbon Tetrachloride affects the expression of CCDC80 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:731978 6480464 Carbon Tetrachloride results in increased expression of CCDC80 mRNA CTD PMID:29987408 , PMID:31919559 titanium dioxide decreases expression ISO RGD:731978 6480464 titanium dioxide results in decreased expression of CCDC80 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CCDC80 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of CCDC80 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:736330 6480464 trichostatin A results in decreased expression of CCDC80 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:736330 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CCDC80 mRNA CTD PMID:27188386 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of CCDC80 mRNA CTD PMID:30589522 valproic acid affects expression ISO RGD:736330 6480464 Valproic Acid affects the expression of CCDC80 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:736330 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CCDC80 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736330 6480464 Valproic Acid results in increased expression of CCDC80 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid decreases expression ISO RGD:736330 6480464 Valproic Acid results in decreased expression of CCDC80 mRNA CTD PMID:26272509 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CCDC80 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CCDC80 mRNA CTD PMID:23034163 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of CCDC80 gene CTD PMID:31079544
